Previous close | 4,153.50 |
Open | 4,092.50 |
Bid | 4,021.00 x N/A |
Ask | 4,033.50 x N/A |
Day's range | 4,000.00 - 4,092.50 |
52-week range | 3,970.00 - 5,400.00 |
Volume | |
Avg. volume | 6,398 |
Market cap | N/A |
Beta (5Y monthly) | 0.51 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 31 July 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Pilgrim's and CVS Health have been highlighted as Zacks Bull and Bear of the Day